Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with HBV-related Solitary Hepatocellular Carcinoma ≤10 cm and without Portal Venous Tumor Thrombus

Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with HBV-related Solitary Hepatocellular Carcinoma ≤10 cm and without Portal Venous Tumor Thrombus is organized by Society for Translational Oncology (STO).

Released: 10/16/2020
Expires: 10/16/2022

CME Accreditation:
The Society for Translational Oncology designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Learning Objectives:
• Use nomograms to divide patients into groups based on risk of postsurgical recurrence or mortality.
• Develop a close postsurgical surveillance protocol and adjuvant therapies based upon the risk groups.